Clinical trial · Observational
Movement Analysis in Musculoskeletal Oncology: a Pilot Study
NCT05918549CI-TRIAL-00073009AnMovunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Noninterventional, prospective, multicenter pilot study of patients with primary and secondary musculoskeletal tumors designed to investigate functional outcomes after therapy using both subjective and quantitative motion detection techniques
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Motion Analysis in Musculoskeletal Oncology | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Motion Analysis in Musculoskeletal Oncology | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Popolation
- interventionNames
- Device: Motion Analysis in Musculoskeletal Oncology
Primary outcomes (1)
- measure
- Quality of life
- timeFrame
- Baseline
- description
- To investigate any differences found using the two methods (quantitative/movement analysis technique versus "subjective"/qualitative technique) in changes in walking/motor characteristics in post-treatment versus pre-treatment. Patients will be monitored via a system of wearable sensors (OPAL 15) which send signals to a computer - station receiving. The system is equipped with 15 small, wireless devices and non-invasive, which contain the following sensors: i) triaxial accelerometer for measuring linear accelerations of the body segment; ii) triaxial gyroscope for measuring angular speeds; iii) triaxial magnetometer, essential for estimating the orientation of the segment in space corporeal. The system synchronously acquires data from each device and sends it via telemetry to one control unit that collects them and saves them in the local database of the computer used for the acquisition.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 6 years * Diagnosis of primary and secondary tumors of the musculoskeletal system * Patients who will need to undergo surgery for bone resection or wide excision of soft tissue lesion, and/or radiation or drug treatments * Availability of follow-up data (for at least 6 months) * Written informed consent Exclusion Criteria: \- Inability to perform pre-post treatment assessment
References
Publications (0)
Data not yet available
No reference posted for this study.